[Report] 143rd HGPI Seminar: "20 Years Since the Enactment of the Basic Act on Cancer Control: Reflecting on the Past and Mapping the Next 20 Years"
HGPI hosted its 143rd seminar, discussing the achievements and future challenges of the 20 years since the enactment of the Basic Act on Cancer Control.
📋 Article Processing Timeline
- 📰 Published: May 21, 2026 at 21:00
- 🔍 Collected: May 21, 2026 at 12:31
- 🤖 AI Analyzed: May 22, 2026 at 02:13 (13h 41m after Collected)
In this HGPI seminar, we welcomed Dr. Fumihiko Wakao, Deputy Director of the Center for Cancer Control and Information Services at the National Cancer Center.
Since his involvement in the launch of the "Cancer Information Service" in 2006, when the Basic Act on Cancer Control was enacted, Dr. Wakao has spent 20 years at the forefront of delivering cancer medical care to citizens, including cancer information provision, patient support, education, and public awareness.
At this seminar, marking the 20th anniversary of the enactment of the Basic Act on Cancer Control in 2006, Dr. Wakao reflected on the journey so far. He also discussed challenges and prospects for the next 20 years, incorporating results from the "National Survey on Cancer: 20 Years Since the Enactment of the Basic Act on Cancer Control," conducted by HGPI in February 2026, which covered 10,000 citizens nationwide, including patients and affected individuals.
## Key Points
- Twenty years after the enactment of the Basic Act on Cancer Control, significant progress has been made in both institutional and medical technological aspects, such as the development of designated cancer care hospitals, the start of the National Cancer Registry, and insurance coverage for cancer genomic medicine. However, these are still at the "started but halfway there" stage, requiring continuous evaluation and improvement.
- Looking ahead to 2040, as a decrease in the working-age population and a shortage of specialists are predicted, the consolidation and equalization of the cancer care provision system have become major policy issues. In surgical therapy, the number of surgeons is estimated to decrease by approximately 40% compared to 2025, making the clarification of regional roles and discussions at the prefectural level essential.
- In the 4th Basic Plan for Cancer Control, a logic model has been introduced, and the development of a data-based evaluation system for cancer control is underway. Although the "yardsticks" such as the National Cancer Registry, hospital-based cancer registries, patient experience surveys, and bereaved family surveys are finally coming together, further strengthening of the data infrastructure supporting the PDCA cycle, such as increasing the participation rate of designated hospitals in patient experience surveys, is necessary.
- A national survey conducted by the Health and Global Policy Institute in February 2026 revealed that 46.8% of citizens "approve" of the consolidation of medical functions, 21.6% "disapprove," and 31.6% "do not know," with over 30% withholding judgment, indicating that public opinion formation is still in progress. Future institutional design will require clear presentation of points at issue, patient and citizen participation, and continuous monitoring through public opinion surveys.
- To realize sustainable cancer care, clarification of the functions of medical institutions, provision of information to citizens, triage by primary care physicians, support for burdens such as transportation, and consensus building based on public understanding are key. These are challenges common to the entire Japanese medical system, not just cancer.
Since his involvement in the launch of the "Cancer Information Service" in 2006, when the Basic Act on Cancer Control was enacted, Dr. Wakao has spent 20 years at the forefront of delivering cancer medical care to citizens, including cancer information provision, patient support, education, and public awareness.
At this seminar, marking the 20th anniversary of the enactment of the Basic Act on Cancer Control in 2006, Dr. Wakao reflected on the journey so far. He also discussed challenges and prospects for the next 20 years, incorporating results from the "National Survey on Cancer: 20 Years Since the Enactment of the Basic Act on Cancer Control," conducted by HGPI in February 2026, which covered 10,000 citizens nationwide, including patients and affected individuals.
## Key Points
- Twenty years after the enactment of the Basic Act on Cancer Control, significant progress has been made in both institutional and medical technological aspects, such as the development of designated cancer care hospitals, the start of the National Cancer Registry, and insurance coverage for cancer genomic medicine. However, these are still at the "started but halfway there" stage, requiring continuous evaluation and improvement.
- Looking ahead to 2040, as a decrease in the working-age population and a shortage of specialists are predicted, the consolidation and equalization of the cancer care provision system have become major policy issues. In surgical therapy, the number of surgeons is estimated to decrease by approximately 40% compared to 2025, making the clarification of regional roles and discussions at the prefectural level essential.
- In the 4th Basic Plan for Cancer Control, a logic model has been introduced, and the development of a data-based evaluation system for cancer control is underway. Although the "yardsticks" such as the National Cancer Registry, hospital-based cancer registries, patient experience surveys, and bereaved family surveys are finally coming together, further strengthening of the data infrastructure supporting the PDCA cycle, such as increasing the participation rate of designated hospitals in patient experience surveys, is necessary.
- A national survey conducted by the Health and Global Policy Institute in February 2026 revealed that 46.8% of citizens "approve" of the consolidation of medical functions, 21.6% "disapprove," and 31.6% "do not know," with over 30% withholding judgment, indicating that public opinion formation is still in progress. Future institutional design will require clear presentation of points at issue, patient and citizen participation, and continuous monitoring through public opinion surveys.
- To realize sustainable cancer care, clarification of the functions of medical institutions, provision of information to citizens, triage by primary care physicians, support for burdens such as transportation, and consensus building based on public understanding are key. These are challenges common to the entire Japanese medical system, not just cancer.
FAQ
がん対策基本法成立から20年でどのような前進がありましたか?
がん診療連携拠点病院の整備、全国がん登録の開始、がんゲノム医療の保険収載など、制度・医療技術の両面で大きな前進が見られました。
2040年に向けたがん医療提供体制の課題は何ですか?
生産年齢人口の減少と専門医不足が予測される中、がん医療提供体制の集約化・均てん化、地域における役割分担の明確化が課題です。
第4期がん対策推進基本計画の特徴は何ですか?
ロジックモデルの導入により、全国がん登録や患者体験調査などのデータを活用した、科学的根拠に基づく評価体系の整備が進められています。
医療機能の集約化に対する市民の意識はどうですか?
日本医療政策機構の全国調査によると、賛成が46.8%、反対が21.6%、わからないが31.6%となっており、意見形成は途上にあります。
持続可能ながん医療の鍵は何ですか?
医療機関の機能明確化、市民への情報提供、かかりつけ医による振り分け、患者支援、そして国民の理解に基づく合意形成が重要です。